Zosano Pharma Corporation (ZSAN)

NASDAQ: ZSAN · IEX Real-Time Price · USD
0.509 -0.021 (-3.89%)
Jan 18, 2022 12:10 PM EST - Market open

Total Valuation

Zosano Pharma has a market cap or net worth of $60.26 million. The enterprise value is $53.67 million.

Market Cap60.26M
Enterprise Value53.67M

Important Dates

The latest earnings date was Friday, November 12, 2021 before market open.

Last Earnings DateNov 12, 2021
Ex-Dividend Daten/a

Share Statistics

Zosano Pharma has 118.35 million shares outstanding. The number of shares has increased by 48.64% in one year.

Shares Outstanding118.35M
Shares Change (YoY)+48.64%
Shares Change (QoQ)+6.26%
Owned by Insiders (%)0.48%
Owned by Institutions (%)10.94%
Float118.14M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio65.36
PB Ratio1.58
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales58.21
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.29.

Current Ratio1.56
Quick Ratio1.51
Debt / Equity0.29
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -72.20%, which is considered low. The company has a ROIC of -79.80%.

Return on Equity (ROE)-72.20%
Return on Assets (ROA)-49.00%
Return on Capital (ROIC)-79.80%
Revenue Per Employee$20,489
Profits Per Employee-$690,044
Employee Count45
Asset Turnover0.02
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -42.46% in the last 52 weeks. The beta is 3.12, so Zosano Pharma's price volatility has been higher than the market average.

Beta (1Y)3.12
52-Week Price Change-42.46%
50-Day Moving Average0.54
200-Day Moving Average0.66
Average Volume (30 Days)2,679,725

Short Selling Information

Short Interest4.54M
Short % of Shares Out3.83%
Short % of Float3.84%
Short Ratio (days to cover)4.06

Income Statement

In the last 12 months, Zosano Pharma had revenue of $922,000 and -31.05 million in losses. Earnings per share was -$0.29.

Revenue922,000
Gross Profit47,000
Operating Income-32.55M
Net Income-31.05M
EBITDA-29.00M
EBIT-30.76M
Earnings Per Share (EPS)-$0.29
Full Income Statement

Balance Sheet

The company has $17.60 million in cash and $11.01 million in debt, giving a net cash position of $6.60 million or $0.06 per share.

Cash & Cash Equivalents17.60M
Total Debt11.01M
Net Cash6.60M
Net Cash Per Share$0.06
Book Value38.20M
Book Value Per Share0.32
Working Capital6.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.04 million and capital expenditures -$5.79 million, giving a free cash flow of -$33.83 million.

Operating Cash Flow-28.04M
Capital Expenditures-5.79M
Free Cash Flow-33.83M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 5.10%, with operating and profit margins of -3,530.48% and -3,367.90%.

Gross Margin5.10%
Operating Margin-3,530.48%
Pretax Marginn/a
Profit Margin-3,367.90%
EBITDA Margin-3,145.55%
EBIT Margin-3,336.01%
FCF Margin-3,669.41%

Dividends & Yields

Zosano Pharma does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-51.53%
FCF Yield-56.14%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on January 26, 2018. It was a reverse split with a ratio of 1:20.

Last Split DateJan 26, 2018
Split TypeReverse
Split Ratio1:20